Associate Director, Finance, US Commercial Sales & GTN Analysis
Bristol Myers Squibb
Summary
The Associate Director, U.S. Commercial Sales & GTN Analysis position provides strategic support to the U.S. business by leading the close and projection pillars of GTN Finance. This role manages the monthly/quarterly accounting close, account reconciliations, and forward-looking gross-to-net projections across the U.S. product portfolio (Oncology, Immunology & Cardiovascular, Neuroscience, CAR-T & Established Brands). The Associate Director owns the integrity of the GTN close (accrual sheets, B/S reconciliations, SOX controls) and the projection/variance analysis that leadership relies on to understand gross-to-net drivers.
Job description
Major Responsibilities and Accountabilities
- Prepare/create budget/projection timelines, presentations, and sales analysis to communicate strategic insights and drivers of gross-net-variances in partnership with Market Access & Pricing, CASA and US Brand Finance teams.
- Manage the monthly/quarterly gross-to-net close process, including accrual sheets for major gross-to-net components (rebates, chargebacks, coupons, discount programs), government payment allocations, and account reconciliations, validating adequacy of accrual balances.
- Lead GTN variance analysis, drivers & commentary, and presentation materials that communicate gross-to-net insights to finance leadership.
- Maintain and update the internal control environment for gross-to-net, supporting internal/external audits and the annual SOX compliance process in partnership with Business Controls.
- Partner with Market Access & Pricing on government/regulatory pricing calculations and related entries and monitor regulatory changes affecting gross-to-net.
- Lead net price and price/volume analysis, returns review, and discount/rebate projection reviews to support quarterly close and forecasting.
- Support brand finance pipeline reviews, driver tie-outs, and the reporting dataset used for GTN reporting.
- Flex into Innovation-pillar initiatives (platform enhancements, dashboard build-outs, process automation testing) leveraging close/projection expertise to inform tool design and validate outputs.
Qualifications
- Minimum education of a bachelor's degree in finance, accounting, economics, information systems, or related field is required.
- CPA or Master of accounting preferred.
- Minimum of seven (7) years of professional experience within finance, accounting, information systems, or related field is required.
- Solid accounting understanding is a must, with a general understanding of the Pharma industry and U.S. healthcare system.
- Strong analytical skills; ability to work effectively across a matrix organization and influence others at all levels.
- Working knowledge of SAP, Power BI, Hyperion, and Anaplan; strong Excel proficiency.
- Experience with SOX controls and external audit support preferred.
Requirements
- Bachelor's degree in finance, accounting, economics, information systems, or related field
- Minimum of seven (7) years of professional experience within finance, accounting, information systems, or related field
- Solid accounting understanding
- General understanding of the Pharma industry and U.S. healthcare system
- Strong analytical skills
- Ability to work effectively across a matrix organization and influence others at all levels
- Working knowledge of SAP, Power BI, Hyperion, and Anaplan
- Strong Excel proficiency
- CPA or Master of accounting preferred
- Experience with SOX controls and external audit support preferred
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Time Off
- 11 Paid Company Holidays
- Paid Sick Leave
- Paid Volunteer Days
- Summer Hours Flexibility
- Leaves of Absence
- Annual Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.